Boston Scientific (NYSE:BSX) underwent analysis by 16 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 7 | 8 | 1 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 3 | 2 | 0 | 0 | 0 |
2M Ago | 0 | 1 | 0 | 0 | 0 |
3M Ago | 4 | 4 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $74.94, a high estimate of $84.00, and a low estimate of $68.00. This current average has increased by 11.62% from the previous average price target of $67.14.
Analyzing Analyst Ratings: A Detailed Breakdown
The standing of Boston Scientific among financial experts is revealed through an in-depth exploration of...
Login or create a forever free account to read this news
Sign up/Log in